相关实验视频
Updated: Sep 18, 2025

06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
22.2K
对人类肺炎病毒的疫苗开发
Elhadji Birane Mboup1, Marie-Ève Hamelin1,2, Julia Dubois2,3,4
1Infectious and Immune Diseases Research Program, CHU de Québec-Université Laval Research Center, Québec, QC G1V 4G2, Canada.
Vaccines
|June 27, 2025
概括
目前已批准了三种呼吸道同胞病毒 (RSV) 疫苗,提供了新的预防方法. 然而,对于人类甲肺炎病毒 (HMPV) 的疫苗仍然是必要的,组合疫苗显示出未来的希望.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 肺炎病毒,包括呼吸道同胞性病毒 (RSV) 和人类甲肺炎病毒 (HMPV),导致全球显著的呼吸道疾病和死亡率.
- 幼儿,老年人和免疫力低下的人特别容易受到严重后果的影响.
- 低收入和中等收入国家承担了不成比例的肺炎病毒相关死亡负担.
研究的目的:
- 审查已批准的RSV疫苗的临床试验.
- 检查RSV疫苗研究中的突出的平台技术.
- 讨论针对RSV,HMPV和人类偏流感病毒3型 (HPIV3) 的组合疫苗.
主要方法:
- 对已批准的RSV疫苗的临床试验数据的分析.
- 审查新兴的RSV疫苗平台技术.
- 在临床开发中讨论组合疫苗候选人.
主要成果:
- 三种RSV疫苗 (AREXVY®,ABRYSVO®,mRESVIA®) 已获得批准,主要用于老年人.
- 艾布里斯沃®通过母体疫苗接种为婴儿提供被动免疫.
- RSV疫苗技术和组合疫苗正在积极临床评估中.
结论:
- 在RSV疫苗开发方面取得了重大进展,有多种已批准的选择.
- 对HMPV的疫苗仍然是一个关键的未满足的医疗需求.
- 组合疫苗代表了一种有前途的战略,可以广泛保护人们免受多种呼吸道病毒的影响.
相关概念视频
Pneumonia V: Nursing management and Prevention
2.5K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.5K
Pneumonia II: Pathophysiology
603
The pathophysiology of pneumonia involves the following steps:
603
Pneumonia I: Introduction
345
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
345
Pneumonia IV: Management
456
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
456

